The IBD Disability Index should become a Major Secondary Endpoint in Clinical Practice and in Clinical Trials

被引：12
|
作者：
Peyrin-Biroulet, Laurent [1 ,2 ]
Gower-Rousseau, Corinne [3 ,4 ,5 ]
机构：
[1] Univ Lorraine, INSERM U954, Allee Morvan, F-54511 Vandoeuvre Les Nancy, France
[2] Univ Lorraine, Dept Hepatogastroenterol, Allee Morvan, F-54511 Vandoeuvre Les Nancy, France
[3] Univ Hosp, EPIMAD Registry, Publ Hlth Epidemiol & Econ Hlth, Reg House Clin Res, F-59000 Lille, France
[4] Univ Hosp, INSERM, UMR 995, Int Ctr Inflammat Res LIRIC, F-59000 Lille, France
[5] IBD & Environm Factors Epidemiol & Funct Anal Grp, F-59000 Lille, France
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷 / 12期
关键词：
QUALITY-OF-LIFE; INTERNATIONAL CLASSIFICATION; VALIDATION; DISEASE;
D O I：
10.1093/ecco-jcc/jjw156
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1375 / 1377
页数：3
相关论文
共 50 条
12345